ZYVERSA THERAPEUTICS, INC. (ZVSA) Operating cash flow 2023–2025
ZYVERSA THERAPEUTICS, INC. (ZVSA) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$5.1MFY2025 · since FY2023: -$8.7M → -$5.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$5.1M | +32.0% |
| FY2024 | -$7.5M | +13.8% |
| FY2023 | -$8.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ZVSA financial trends
ZVSA RevenueZVSA Net incomeZVSA Net marginZVSA Gross profitZVSA Gross marginZVSA Operating incomeZVSA Operating marginZVSA Free cash flowZVSA Capital expendituresZVSA Return on equityZVSA Stock buybacksZVSA Dividends paidZVSA Total assetsZVSA Total liabilitiesZVSA Shareholders’ equityZVSA overview →